New drug duo tested to fight advanced throat cancer
NCT ID NCT07381699
Summary
This study is testing a new two-drug combination as the first treatment for people with advanced nasopharyngeal cancer that has come back or spread. It aims to see if the drugs Becotatug Vedotin and Pucotenlimab are safe and effective at controlling the cancer. The trial will enroll about 30 patients who have not yet received treatment for their advanced cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CANCINOMA (NPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.